Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
LIC MF Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.10.1018538519.1908
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.540667235.0409
Domestic EquitiesTorrent Pharmaceuticals Ltd.5.4001131304.9131
Domestic EquitiesCipla Ltd.5.3343312184.8532
Domestic EquitiesDivi's Laboratories Ltd.4.464161584.0615
Domestic EquitiesFortis Healthcare Ltd.3.9678421023.6100
Domestic EquitiesAurobindo Pharma Ltd.3.9213313013.5677
Domestic EquitiesPiramal Pharma Ltd.3.72721721113.3911
Domestic EquitiesAbbott India Ltd.3.66059683.3304
Domestic EquitiesNeuland Laboratories Ltd.3.523824143.2060
Domestic EquitiesAlkem Laboratories Ltd.3.435162123.1253
Domestic EquitiesGland Pharma Ltd.3.0299133512.7567
Domestic EquitiesIPCA Laboratories Ltd.2.9664183112.6989
Domestic EquitiesArtemis Medicare Services Ltd.2.85951088322.6016
Domestic EquitiesGlenmark Pharmaceuticals Ltd.2.8133119942.5596
Domestic EquitiesNavin Fluorine International Ltd.2.660947962.4209
Domestic EquitiesMetropolis Healthcare Ltd.2.5038114172.2780
Domestic EquitiesDr Agarwal's Health Care Ltd.2.4948496842.2698
Domestic EquitiesMankind Pharma Ltd.2.420285772.2019
Domestic EquitiesConcord Biotech Ltd.2.3972123412.1810
Domestic EquitiesMax Healthcare Institute Ltd.2.2974167752.0902
Domestic EquitiesSyngene International Ltd.2.2178282602.0178
Domestic EquitiesGlobal Health Ltd.2.1548149521.9605
Domestic EquitiesJB Chemicals & Pharmaceuticals Ltd.1.893397361.7226
Domestic EquitiesVinati Organics Ltd.1.758487411.5998
Domestic EquitiesOnesource Specialty Pharma Ltd.1.590873321.4473
Domestic EquitiesCohance Lifesciences Ltd.1.4821135051.3484
Domestic EquitiesAcutaas Chemicals Ltd.1.416897111.2890
Domestic EquitiesZydus Lifesciences Ltd.1.3812129571.2566
Domestic EquitiesLinde India Ltd.1.126415591.0248
Domestic EquitiesAnthem Biosciences Ltd.1.0460125360.9517
Total 95.5875 86.9671
Cash & Cash Equivalents and Net AssetsTreps4.4687 4.0657
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.0562 -0.0511
Total 4.4125 4.0146
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.